mapk1-protein

📖 Wiki Page

protein1522 wordssynced 2026-04-02

mapk1-protein

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">MAPK1/ERK2 Protein</th>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Mitogen-Activated Protein Kinase 1 / Extracellular Signal-Regulated Kinase 2</td>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>MAPK1</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>MAP kinase family (MAPK/ERK)</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Chromosome 22q11.21</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>41.4 kDa (ERK2 isoform)</td>
</tr>
<tr>
<td class="label">Function</td>
<td>Serine/Threonine Kinase, cell signaling</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/atherosclerosis" style="color:#ef9a9a">Atherosclerosis</a>, <a href="/wiki/autism" style="color:#ef9a9a">Autism</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">422 edges</a></td>
</tr>
</table>

MAPK1 Protein (ERK2)

Overview

...

mapk1-protein

MAPK1 Protein (ERK2)

Overview

MAPK1 (Mitogen-Activated Protein Kinase 1), also known as ERK2 (Extracellular Signal-Regulated Kinase 2), is a member of the MAP kinase family that plays central roles in cellular signaling, neuronal function, and disease pathogenesis. The MAPK/ERK signaling pathway is one of the most important cascades in eukaryotic cells, regulating cell proliferation, differentiation, survival, and plasticity. In the brain, MAPK1/ERK2 is critically involved in synaptic plasticity, learning and memory, and neuronal development[@ortenzio2012].

The MAPK1 gene encodes two isoforms through alternative translation initiation: ERK1 (MAPK3, ~44 kDa) and ERK2 (MAPK1, ~41 kDa). While these isoforms have overlapping functions, ERK2 is more widely expressed and considered the prototypical MAP kinase. The protein is activated by a cascade of kinases (Raf → MEK → ERK) in response to growth factors, neurotransmitters, and cellular stress.

Dysregulation of MAPK1/ERK2 signaling has been implicated in multiple neurodegenerative diseases, including [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and [amyotrophic lateral sclerosis](/diseases/amyotrophic-lateral-sclerosis)[@cervantes2021][@kim2019]. The pathway is involved in protein phosphorylation, neuroinflammation, synaptic dysfunction, and neuronal death.

Gene Structure and Expression

Gene Organization

The MAPK1 gene is located on chromosome 22q11.21 and spans approximately 35 kb. It consists of 9 exons and encodes a 360-amino acid protein (ERK2 isoform). Alternative splicing generates additional variants with distinct expression patterns and functions[@pearson2021].

Protein Structure

ERK2 has a characteristic MAP kinase fold:

N-terminal Domain: Contains the kinase activity and substrate-binding pocket.

C-terminal Domain: Regulatory features including the activation loop.

Phosphorylation Sites: Threonine-185 and Tyrosine-187 in the activation loop (the TEY motif) are essential for activity.

Docking Domains: D- and F- sites for interaction with substrates and regulators.

Tissue Distribution

MAPK1/ERK2 is ubiquitously expressed with high levels in brain:

Neurons: High expression in cortex, hippocampus, and cerebellum
Glia: Expression in astrocytes and microglia
Synapses: Postsynaptic density localization
Development: Higher expression during neurodevelopment

Biological Functions

Signal Transduction

The MAPK/ERK pathway is a central signaling cascade[@ortenzio2012]:

Upstream Activation: Receptor tyrosine kinases, GPCRs, and ion channels activate the cascade.

Kinase Cascade: Raf → MEK1/2 → ERK1/2

Nuclear Import: Phosphorylated ERK translocates to the nucleus.

Transcriptional Regulation: Phosphorylates transcription factors including Elk-1, c-Fos, and c-Myc.

Neuronal Development

MAPK1/ERK2 plays critical roles in brain development[@gomez2018]:

Neurogenesis: Regulates neural progenitor cell proliferation and differentiation.

Neurite Outgrowth: Promotes axonal and dendritic growth.

Synaptogenesis: Controls formation of excitatory synapses.

Cell Survival: Supports neuronal survival during development.

Synaptic Plasticity

ERK2 is essential for synaptic plasticity and memory[@zhang2017][@liu2020]:

Long-term Potentiation (LTP): ERK activation is required for LTP induction and maintenance.

Long-term Depression (LTP): Involved in LTD mechanisms.

Protein Synthesis: Controls local translation at synapses.

BDNF Signaling: Mediates brain-derived neurotrophic factor effects.

Cell Survival and Death

MAPK1/ERK2 has dual, context-dependent effects on cell survival[@kim2019]:

Pro-survival Functions: In early stages, ERK activation promotes survival.

Pro-death Effects: Chronic or excessive activation can lead to apoptosis.

Cross-talk with Other Pathways: Interactions with PI3K/Akt and other survival pathways.

Role in Neurodegenerative Diseases

Alzheimer's Disease

MAPK1/ERK2 is critically involved in Alzheimer's disease pathogenesis[@cervantes2021][@sun2018][@crowe2015]:

Tau Phosphorylation: ERK2 phosphorylates tau at multiple sites including Ser-202, Thr-205, and Ser-396. This hyperphosphorylation contributes to neurofibrillary tangle formation.

Amyloid-beta Signaling: Aβ oligomers activate MAPK/ERK pathway. This activation contributes to synaptic dysfunction and neuronal death.

Synaptic Dysfunction: ERK2-mediated signaling regulates AMPA receptor trafficking and synaptic plasticity. Dysregulation contributes to memory deficits.

Neuroinflammation: ERK activation in microglia promotes production of pro-inflammatory cytokines.

Therapeutic Targeting: MAPK inhibitors are being investigated for AD treatment[@choi2019][@kim2018].

Parkinson's Disease

In Parkinson's disease, MAPK1/ERK2 contributes to dopaminergic neuron dysfunction[@mehta2019][@kim2020]:

Dopaminergic Neuron Vulnerability: MAPK/ERK dysregulation contributes to substantia nigra neuron death.

Alpha-synuclein Pathology: ERK2 may influence alpha-synuclein phosphorylation and aggregation.

Mitochondrial Dysfunction: MAPK signaling intersects with PINK1/Parkin pathways.

Neuroinflammation: Glial MAPK activation promotes neuroinflammation.

Therapeutic Potential: Modulating ERK signaling may provide neuroprotection.

Amyotrophic Lateral Sclerosis (ALS)

ERK1/2 activation is observed in ALS and contributes to motor neuron degeneration[@rizzo2016]:

Sporadic and Familial ALS: Both show elevated ERK phosphorylation.

Glial Activation: Microglial ERK contributes to neuroinflammation.

Axonal Degeneration: ERK-mediated pathways affect axonal integrity.

Therapeutic Implications: MAPK inhibitors may provide benefits.

Huntington's Disease

MAPK/ERK signaling is dysregulated in Huntington's disease[@thacker2018]:

Mutant Huntingtin Effects: Alters MAPK pathway activation and function.

Transcriptional Dysregulation: ERK-mediated transcription is affected.

Synaptic Dysfunction: Contributes to synaptic deficits.

Therapeutic Targeting: MAPK modulation may improve function.

Other Conditions

Traumatic Brain Injury: ERK activation contributes to both injury and repair processes[@zhao2018].

Stroke: Dual roles in acute injury and recovery.

Mechanisms in Neurodegeneration

Protein Phosphorylation

ERK2-mediated phosphorylation affects multiple targets:

Tau: Hyperphosphorylation at multiple AD-relevant sites.

Amyloid Precursor Protein (APP): Affects processing and Aβ production.

Synaptic Proteins: Modulates glutamate receptor function.

Transcription Factors: Alters gene expression patterns.

Neuroinflammation

ERK signaling promotes neuroinflammation[@chu2018]:

Microglial Activation: ERK activation triggers pro-inflammatory responses.

Cytokine Production: Controls TNF-alpha, IL-1beta, and IL-6 production.

Nitric Oxide: Regulates iNOS and NO production.

Cyclooxygenase: Affects prostaglandin synthesis.

Oxidative Stress

ERK is involved in oxidative stress responses[@song2019]:

ROS Production: Can promote reactive oxygen species generation.

Antioxidant Genes: Regulates Nrf2 and antioxidant responses.

Apoptosis: Mediates stress-induced cell death.

Autophagy

ERK signaling modulates autophagy[@yang2019]:

Autophagosome Formation: Affects initiation and completion.

Lysosomal Function: Modulates degradation pathways.

Protein Clearance: Impaired in neurodegenerative diseases.

Research Methods

Detection and Analysis

Phospho-specific Antibodies: Detect activated (phosphorylated) ERK.

Western Blot: Measure total and phospho-ERK levels.

Immunohistochemistry: Localize ERK in brain tissue.

Kinase Assays: Measure ERK catalytic activity.

Experimental Approaches

Cell Culture: Primary neurons, cell lines for mechanism studies.

Animal Models: Transgenic and knockout mice.

Inhibitors: MEK inhibitors (U0126, PD98059) block ERK activation.

CRISPR: Genetic manipulation of MAPK1.

Therapeutic Approaches

MEK Inhibitors: Block upstream activation of ERK[@martinez2020].

ERK Inhibitors: Direct kinase inhibitors.

Modulators: Compounds that modulate pathway activity.

Clinical Significance

Therapeutic Target

MAPK1/ERK2 is a promising therapeutic target:

Alzheimer's Disease: MEK inhibitors in clinical trials.

Parkinson's Disease: Neuroprotective strategies.

ALS: Anti-inflammatory approaches.

Challenges: Optimal timing, blood-brain barrier penetration, side effects.

Biomarker Potential

ERK phosphorylation may serve as a biomarker:

CSF Biomarkers: Phospho-ERK levels in cerebrospinal fluid.

Blood Biomarkers: Peripheral measures.

Disease Progression: Correlates with severity.

Interactions and Pathways

Upstream Regulators

Receptor Tyrosine Kinases: Growth factor receptors.

G-protein-coupled Receptors: Neurotransmitter receptors.

Ion Channels: Activity-dependent activation.

Downstream Targets

Transcription Factors: Elk-1, c-Fos, c-Myc, CREB.

Kinases: RSK, MSK, MNK.

Cytoskeletal Proteins: Tau, MAPs.

Cross-talk Pathways

PI3K/Akt: Intersects with survival signaling.

JNK/p38: Other MAP kinase families.

PKC: Protein kinase C interactions.

Animal Models

Knockout Studies

MAPK1 knockout mice: embryonic lethal (partial redundancy with MAPK3)
Conditional knockouts: neuronal-specific deletion
Transgenic models: expressing active/inactive ERK

Disease Models

APP/PS1 mice: ERK activation in amyloid models
MPTP model: PD-like ERK changes
SOD1 mice: ALS-like ERK activation

Future Directions

Research Priorities

Understanding cell-type specific functions
Optimal therapeutic modulation strategies
Biomarker development
Combination therapies

Emerging Approaches

Selective MAPK inhibitors
Targeted delivery methods
Precision medicine approaches

References

[Cervantes S, et al, MAPK signaling in Alzheimer's disease pathogenesis (2021)](https://pubmed.ncbi.nlm.nih.gov/34089023/)

[Kim EK, Choi EJ, MAPK pathways in neurodegeneration and neuroprotection (2019)](https://pubmed.ncbi.nlm.nih.gov/31138947/)

[Ortenzio G, et al, ERK1/2 in brain function and disease (2012)](https://pubmed.ncbi.nlm.nih.gov/22747006/)

[Mehta P, et al, ERK1/2 in Parkinson's disease dopaminergic neurons (2019)](https://pubmed.ncbi.nlm.nih.gov/31190438/)

[Sun J, et al, ERK1/2 and tau phosphorylation in Alzheimer's disease (2018)](https://pubmed.ncbi.nlm.nih.gov/29625148/)

[Zhang Y, et al, ERK1/2 in synaptic plasticity and memory (2017)](https://pubmed.ncbi.nlm.nih.gov/28716922/)

[Crowe SL, et al, ERK1/2 activation in amyloid-beta toxicity (2015)](https://pubmed.ncbi.nlm.nih.gov/25752821/)

[Chu J, et al, ERK1/2 and neuroinflammation in neurodegenerative disease (2018)](https://pubmed.ncbi.nlm.nih.gov/30594209/)

[Rizzo FR, et al, ERK1/2 in ALS and motor neuron disease (2016)](https://pubmed.ncbi.nlm.nih.gov/26948811/)

[Thacker JS, et al, ERK1/2 in Huntington's disease (2018)](https://pubmed.ncbi.nlm.nih.gov/30059391/)

[Pearson G, et al, ERK1/2 structure and activation mechanism (2021)](https://pubmed.ncbi.nlm.nih.gov/34055528/)

[Kim J, et al, MAPK inhibitors in neurodegenerative disease clinical trials (2018)](https://pubmed.ncbi.nlm.nih.gov/29920590/)

[Song J, et al, ERK1/2 and oxidative stress in neurodegeneration (2019)](https://pubmed.ncbi.nlm.nih.gov/30880504/)

[Gomez N, et al, ERK1/2 in neuronal development (2018)](https://pubmed.ncbi.nlm.nih.gov/29498567/)

[Choi JM, et al, Targeting ERK1/2 for therapeutic intervention in AD (2019)](https://pubmed.ncbi.nlm.nih.gov/30857952/)

[Kim H, et al, ERK1/2 and alpha-synuclein in Parkinson's disease (2020)](https://pubmed.ncbi.nlm.nih.gov/32761279/)

[Yang L, et al, ERK1/2 in autophagy and protein clearance (2019)](https://pubmed.ncbi.nlm.nih.gov/30864882/)

[Liu Z, et al, ERK1/2 and BDNF signaling in synaptic plasticity (2020)](https://pubmed.ncbi.nlm.nih.gov/31820845/)

[Zhao W, et al, ERK1/2 in traumatic brain injury and repair (2018)](https://pubmed.ncbi.nlm.nih.gov/30146623/)

[Martinez A, et al, Small molecule MAPK inhibitors for neuroprotection (2020)](https://pubmed.ncbi.nlm.nih.gov/32097652/)

📖 View canonical wiki page →

mapk1-protein

mapk1-protein

MAPK1 Protein (ERK2)

Overview

mapk1-protein

MAPK1 Protein (ERK2)

Overview

Gene Structure and Expression

Gene Organization

Protein Structure

Tissue Distribution

Biological Functions

Signal Transduction

Neuronal Development

Synaptic Plasticity

Cell Survival and Death

Role in Neurodegenerative Diseases

Alzheimer's Disease

Parkinson's Disease

Amyotrophic Lateral Sclerosis (ALS)

Huntington's Disease

Other Conditions

Mechanisms in Neurodegeneration

Protein Phosphorylation

Neuroinflammation

Oxidative Stress

Autophagy

Research Methods

Detection and Analysis

Experimental Approaches

Therapeutic Approaches

Clinical Significance

Therapeutic Target

Biomarker Potential

Interactions and Pathways

Upstream Regulators

Downstream Targets

Cross-talk Pathways

Animal Models

Knockout Studies

Disease Models

Future Directions

Research Priorities

Emerging Approaches

See Also

References